产后立即开始使用醋酸甲羟孕酮的女性静脉血栓栓塞症风险
基于2005至2014年IBM MarketScan商业理赔数据库,纳入15-44岁分娩住院女性,比较产后0-7天启动DMPA者与未启动激素避孕者在产后12周内VTE发生风险,调整年龄及妊娠相关和慢性疾病后,DMPA组VTE调整发病率比为1.94(95%CI 1.38-2.72)。
要点
- 产后立即启动DMPA者12周内VTE未调整发病率为0.42/10,000女性日,对照组为0.15/10,000女性日。
- 仅调整年龄时VTE发病率比为2.87(95%CI 2.05-4.03)。
- 调整年龄及妊娠相关和慢性疾病后VTE调整发病率比为1.94(95%CI 1.38-2.72)。
核心结论
- 产后立即启动DMPA与VTE发生率低但相对风险升高相关,相比未使用激素避孕者。
研究设计与样本
- 使用IBM MarketScan商业理赔与 encounters 数据库识别2005至2014年15-44岁女性分娩住院记录。
- 产后0-7天启动DMPA的女性与同期未启动激素避孕的女性进行比较。
- 从分娩日期随访至产后12周,随访终点为VTE发生,删失于启动或处方激素避孕、子宫切除、绝育或住院死亡。
主要发现
- 产后立即DMPA组12周内VTE未调整发病率为0.42/10,000女性日(11,159名女性中34例事件,贡献805,999女性日随访)。
- 对照组12周内VTE未调整发病率为0.15/10,000女性日(3,102,011名女性中3,107例事件,贡献206,180,811女性日随访)。
- 仅调整年龄的VTE发病率比为2.87(95%CI 2.05-4.03),DMPA组对比对照组。
- 调整年龄及妊娠相关和慢性疾病后VTE调整发病率比为1.94(95%CI 1.38-2.72),DMPA组对比对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the absolute and relative risk of venous thromboembolism (VTE) among women who initiate depot medroxyprogesterone acetate (DMPA) immediately postpartum compared with those who do not initiate hormonal contraception. METHODS: The IBM MarketScan Commercial Claims and Encounters databases were used to identify delivery hospitalizations among women aged 15-44 years during 2005 through 2014. Diagnosis, procedure, and drug codes were used to identify contraception, VTE, and potential confounding chronic or pregnancy-related conditions. Women who initiated DMPA during days 0 through 7 postpartum were compared with women who did not initiate hormonal contraception during days 0 through 7 postpartum. Women were followed from date of delivery through 12 weeks postpartum for the occurrence of VTE, with censoring at hormonal contraception initiation or prescription, hysterectomy, sterilization, or inpatient death. The incidence rate of VTE and 95% CIs were calculated within each group and the incidence rate ratio was calculated comparing the two groups. RESULTS: The unadjusted VTE incidence rate through 12 weeks postpartum was 0.42/10,000 women-days in the immediate postpartum DMPA group (34 events among 11,159 women contributing 805,999 days of follow-up) and 0.15/10,000 women-days in the control group (3,107 events among 3,102,011 women contributing 206,180,811 days of follow-up). The incidence rate ratio for VTE was 2.87 (95% CI 2.05-4.03) among women in the immediate postpartum DMPA group compared with women in the control group, adjusting for age alone. After adjusting for age and pregnancy-related and chronic conditions, the adjusted incidence rate ratio for VTE was 1.94 (95% CI 1.38-2.72) among women in the immediate postpartum DMPA group compared with women in the control group. CONCLUSION: Initiation of DMPA immediately postpartum is associated with a low incidence but an increased relative risk of VTE compared with nonuse of hormonal contraception.
引用
- Tepper NK, Jeng G, Curtis KM, et al. Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum. Obstet Gynecol. 2019. PMID: 30741807. doi:10.1097/AOG.0000000000003135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。